臨床試驗

Tract Closure in PCNL

NCT：NCT07668817 · RECRUITING

NCT IDNCT07668817

狀態RECRUITING

開始日期2026-10-26

SponsorIcahn School of Medicine at Mount Sinai (OTHER)

First posted2026-06-25

Last updated2026-09-18

簡要摘要

This is a prospective, randomized controlled trial evaluating the effect of a hemostatic agent on tract-related bleeding during percutaneous nephrolithotomy (PCNL). Patients undergoing standardized PCNL will be randomized to receive either application of a hemostatic agent or no agent during tract closure, following uniform balloon occlusion, complete aspiration, and irrigation-free endoscopic assessment. The researchers hypothesize that adjunctive hemostatic agent use reduces perioperative hemoglobin decline compared with balloon tamponade alone and improves tract-related hemostasis outcomes.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。